Overview
Shuhei Azekawa practices in Shinjuku, Japan. Mr. Azekawa is rated as an Advanced expert by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Long Haul COVID, and Pneumonia.
His clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 23 articles in the study of COVID-19.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Mr. Azekawa isAdvanced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- FluMr. Azekawa isExperienced. Learn about Flu.
- Long Haul COVIDMr. Azekawa isExperienced. Learn about Long Haul COVID.
- Mycobacterium Avium Complex InfectionsMr. Azekawa isExperienced. Learn about Mycobacterium Avium Complex Infections.
- PneumoniaMr. Azekawa isExperienced. Learn about Pneumonia.
- ThrushMr. Azekawa isExperienced. Learn about Thrush.